Lymphangioleiomyomatosis: a complex tale of serum response factor-mediated tissue inhibitor of metalloproteinase-3 regulation.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  American Journal of Respiratory Cell and Molecular Biology

• Publication date

  2003-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1165/RCMB.F267PMID 12707009
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lymphangioleiomyomatosis

  2021cited by this paper
• Tissue inhibitor of metalloproteinase-3 downregulation in lymphangioleiomyomatosis: potential consequence of abnormal serum response factor expression.

  2003cited by this paper
• The RhoA/Rho kinase pathway regulates nuclear localization of serum response factor.

  2003cited by this paper
• Tumour suppressors hamartin and tuberin: intracellular signalling.

  2003cited by this paper
• Recurrent lymphangiomyomatosis after transplantation: genetic analyses reveal a metastatic mechanism.

  2003cited by this paper
• 14-3-3 interacts with the tumor suppressor tuberin at Akt phosphorylation site(s).

  2002cited by this paper
• TSC1–TSC2: a complex tale of PKB-mediated S6K regulation

  2002cited by this paper
• Nuclear architecture and spatial positioning help establish transcriptional states of telomeres in yeast

  2002cited by this paper
• The role of matrix metalloproteinase polymorphisms in the rate of decline in lung function.

  2002cited by this paper
• Overlapping and enzyme-specific contributions of matrix metalloproteinases-9 and -12 in IL-13-induced inflammation and remodeling.

  2002cited by this paper
• Identification and Characterization of the Interaction between Tuberin and 14-3-3ζ*

  2002cited by this paper
• A calmodulin binding site in the tuberous sclerosis 2 gene product is essential for regulation of transcription events and is altered by mutations linked to tuberous sclerosis and lymphangioleiomyomatosis.

  2002cited by this paper
• Regulation of TSC2 by 14-3-3 Binding*

  2002cited by this paper
• Phosphatidylinositol 3-Kinase/Akt Pathway Regulates Tuberous Sclerosis Tumor Suppressor Complex by Phosphorylation of Tuberin*

  2002cited by this paper
• Tuberin Regulates p70 S6 Kinase Activation and Ribosomal Protein S6 Phosphorylation

  2002cited by this paper
• Human collagenase (matrix metalloproteinase-1) expression in the lungs of patients with emphysema.

  2001cited by this paper
• Genetic polymorphism in matrix metalloproteinase-9 and pulmonary emphysema.

  2001cited by this paper
• Pathological mutations in TSC1 and TSC2 disrupt the interaction between hamartin and tuberin.

  2001cited by this paper
• Chromosome 16 loss of heterozygosity in tuberous sclerosis and sporadic lymphangiomyomatosis.

  2001cited by this paper
• NF1 tumor suppressor gene function: narrowing the GAP.

  2001cited by this paper
• Tissue inhibitor of metalloproteinases-2 gene polymorphisms in chronic obstructive pulmonary disease.

  2001cited by this paper
• Spontaneous air space enlargement in the lungs of mice lacking tissue inhibitor of metalloproteinases-3 (TIMP-3).

  2001cited by this paper
• Role of S6 phosphorylation and S6 kinase in cell growth.

  2001cited by this paper
• TOR, a central controller of cell growth.

  2000cited by this paper
• Molecular genetic advances in tuberous sclerosis

  2000cited by this paper
• Role for activation of matrix metalloproteinases in the pathogenesis of pulmonary lymphangioleiomyomatosis.

  2000cited by this paper
• Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis.

  2000cited by this paper
• Proliferation, but not growth, blocked by conditional deletion of 40S ribosomal protein S6.

  2000cited by this paper
• Interferon γ Induction of Pulmonary Emphysema in the Adult Murine Lung

  2000cited by this paper
• The TSC1 tumour suppressor hamartin regulates cell adhesion through ERM proteins and the GTPase Rho

  2000cited by this paper
• Physiological Control of Smooth Muscle-specific Gene Expression through Regulated Nuclear Translocation of Serum Response Factor*

  2000cited by this paper
• Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema.

  2000cited by this paper
• eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation.

  1999cited by this paper
• Characterization of the Cytosolic Tuberin-Hamartin Complex

  1999cited by this paper
• New developments in the neurobiology of the tuberous sclerosis complex.

  1999cited by this paper
• Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. TIMP-3 promotes apoptosis.

  1998cited by this paper
• Molecular control of vascular smooth muscle cell differentiation.

  1998cited by this paper
• Serum response factor is essential for mesoderm formation during mouse embryogenesis

  1998cited by this paper
• Adenovirus-mediated gene delivery of tissue inhibitor of metalloproteinases-3 inhibits invasion and induces apoptosis in melanoma cells.

  1998cited by this paper
• Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34.

  1997cited by this paper
• Immunohistochemical study of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in pulmonary lymphangioleiomyomatosis (LAM).

  1997cited by this paper
• TIMP-3 induces cell death by stabilizing TNF-alpha receptors on the surface of human colon carcinoma cells.

  1997cited by this paper
• Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice.

  1997cited by this paper
• Presence of potent transcriptional activation domains in the predisposing tuberous sclerosis (Tsc2) gene product of the Eker rat model.

  1996cited by this paper
• Comparative analysis and genomic structure of the tuberous sclerosis 2 (TSC2) gene in human and pufferfish.

  1996cited by this paper
• Comparative analysis and genomic structure of the tuberous sclerosis 2 (TSC2) gene in human and pufferfish.

  1996cited by this paper
• The Rho family GTPases RhoA, Racl , and CDC42Hsregulate transcriptional activation by SRF

  1995cited by this paper
• Regulation of differentiation of vascular smooth muscle cells.

  1995cited by this paper
• Elastolytic metalloproteinases produced by human mononuclear phagocytes. Potential roles in destructive lung disease.

  1994cited by this paper
• Identification and characterization of the tuberous sclerosis gene on chromosome 16

  1993cited by this paper
• Localization of the rap1GAP catalytic domain and sites of phosphorylation by mutational analysis

  1992cited by this paper
• Collagenase expression in the lungs of transgenic mice causes pulmonary emphysema.

  1992cited by this paper
• The serum response element.

  1992cited by this paper
• Molecular cloning of a GTPase activating protein specific for the Krev-1 protein p21rap1.

  1991cited by this paper
• Human 92- and 72-kilodalton type IV collagenases are elastases.

  1991cited by this paper
• Role of elastic fiber degradation in emphysema-like lesions of pulmonary lymphangiomyomatosis.

  1990cited by this paper

• The development for emerging biomarkers of lymphangioleiomyomatosis

  2024cites this paper
• Diffuse Cystic Lung Diseases

  2019cites this paper
• Dysregulation of the endothelin pathway in lymphangioleiomyomatosis with no direct effect on cell proliferation and migration

  2018cites this paper
• Urokinase-type plasminogen activator (uPA) is critical for progression of tuberous sclerosis complex 2 (TSC2)-deficient tumors

  2017cites this paper
• New insights in lymphangioleiomyomatosis and pulmonary Langerhans cell histiocytosis

  2017cites this paper
• [Pulmonary lymphangioleiomyomatosis: From pathogenesis to management].

  2016cites this paper
• Clinical features, epidemiology, and therapy of lymphangioleiomyomatosis

  2015cites this paper
• Clinical features, epidemiology, and therapy of lymphangioleiomyomatosis

  2015cites this paper
• The changing face of a rare disease: lymphangioleiomyomatosis

  2015cites this paper
• Management of lymphangioleiomyomatosis

  2014cites this paper
• Sustained effects of sirolimus on lung function and cystic lung lesions in lymphangioleiomyomatosis.

  2014cites this paper
• Therapeutic strategies for treatment of pulmonary lymphangioleiomyomatosis

  2014cites this paper
• Linfangioleiomiomatosis pulmonar y gestación

  2013cites this paper
• Targeting the Phosphatidylinositol 3-Kinase Pathway in Airway Smooth Muscle

  2012cites this paper
• Prevention of Alveolar Destruction and Airspace Enlargement in a Mouse Model of Pulmonary Lymphangioleiomyomatosis (LAM)

  2012cites this paper
• Impaired social interactions and motor learning skills in tuberous sclerosis complex model mice expressing a dominant/negative form of tuberin.

  2012cites this paper
• Optimizing treatments for lymphangioleiomyomatosis

  2012cites this paper
• Treating metastatic soft-tissue or bone sarcomas – potential role of ridaforolimus

  2012cites this paper
• Lymphangioleiomyomatosis.

  2011cites this paper
• The Natural History of Lymphangioleiomyomatosis: Markers of Severity, Rate of Progression and Prognosis

  2010cites this paper
• Involvement of Lymphatics in Lymphangioleiomyomatosis

  2009cites this paper
• Therapeutic options for lymphangioleiomyomatosis (LAM): where we are and where we are going

  2009cites this paper
• Reversible airflow obstruction in lymphangioleiomyomatosis.

  2009cites this paper
• Pulmonary lymphangioleiomyomatosis (LAM): Progress and current challenges

  2008cites this paper
• Lymphangioleiomyomatosis and Tuberous Sclerosis Complex

  2008cites this paper
• Interferon β Augments Tuberous Sclerosis Complex 2 (TSC2)-Dependent Inhibition of TSC2-Null ELT3 and Human Lymphangioleiomyomatosis-Derived Cell Proliferation

  2008cites this paper
• Smooth muscle-like cells in pulmonary lymphangioleiomyomatosis.

  2008cites this paper
• Lymphatic Involvement in Lymphangioleiomyomatosis

  2008cites this paper
• Interferon (cid:1) Augments Tuberous Sclerosis Complex 2 (TSC2)-Dependent Inhibition of TSC2-Null ELT3 and Human Lymphangioleiomyomatosis-Derived Cell Proliferation

  2008cites this paper
• Interferon beta augments tuberous sclerosis complex 2 (TSC2)-dependent inhibition of TSC2-null ELT3 and human lymphangioleiomyomatosis-derived cell proliferation.

  2008cites this paper
• Capítulo nueve – Enfermedades pulmonares intersticiales crónicas

  2006cites this paper
• Lymphangioleiomyomatosis.

  2006cites this paper
• Modulation of cell migration and invasiveness by tumor suppressor TSC2 in lymphangioleiomyomatosis.

  2006cites this paper
• ADAM33: a newly identified gene in the pathogenesis of asthma.

  2005cites this paper
• Clinical and molecular insights into lymphangioleiomyomatosis.

  2005cites this paper
• An expanding role for mTOR in cancer.

  2005cites this paper
• Maladies orphelines pulmonaires. De la curiosité à la sollicitude. Discussion

  2004cites this paper
• The role of ADAM33 in the pathogenesis of asthma

  2004cites this paper
• [Orphan lung diseases: from curiosity to concern].

  2004cites this paper
• TSC2 modulates actin cytoskeleton and focal adhesion through TSC1-binding domain and the Rac1 GTPase

  2004influential citation